Product Code: ETC12837417 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Africa Inflammatory Bowel Disease Therapeutics Market Overview |
3.1 South Africa Country Macro Economic Indicators |
3.2 South Africa Inflammatory Bowel Disease Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 South Africa Inflammatory Bowel Disease Therapeutics Market - Industry Life Cycle |
3.4 South Africa Inflammatory Bowel Disease Therapeutics Market - Porter's Five Forces |
3.5 South Africa Inflammatory Bowel Disease Therapeutics Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 South Africa Inflammatory Bowel Disease Therapeutics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 South Africa Inflammatory Bowel Disease Therapeutics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 South Africa Inflammatory Bowel Disease Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of inflammatory bowel disease (IBD) in South Africa |
4.2.2 Growing awareness and diagnosis rates of IBD in the country |
4.2.3 Advances in medical research leading to the development of innovative therapies for IBD |
4.3 Market Restraints |
4.3.1 High cost of IBD therapeutics limiting accessibility for some patients |
4.3.2 Limited healthcare infrastructure and resources in certain regions of South Africa |
4.3.3 Regulatory challenges and delays in drug approvals impacting market growth |
5 South Africa Inflammatory Bowel Disease Therapeutics Market Trends |
6 South Africa Inflammatory Bowel Disease Therapeutics Market, By Types |
6.1 South Africa Inflammatory Bowel Disease Therapeutics Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 South Africa Inflammatory Bowel Disease Therapeutics Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 South Africa Inflammatory Bowel Disease Therapeutics Market Revenues & Volume, By Aminosalicylates, 2021 - 2031F |
6.1.4 South Africa Inflammatory Bowel Disease Therapeutics Market Revenues & Volume, By Corticosteroids, 2021 - 2031F |
6.1.5 South Africa Inflammatory Bowel Disease Therapeutics Market Revenues & Volume, By Immunomodulators, 2021 - 2031F |
6.1.6 South Africa Inflammatory Bowel Disease Therapeutics Market Revenues & Volume, By JAK Inhibitors, 2021 - 2031F |
6.1.7 South Africa Inflammatory Bowel Disease Therapeutics Market Revenues & Volume, By Antibiotics, 2021 - 2031F |
6.2 South Africa Inflammatory Bowel Disease Therapeutics Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 South Africa Inflammatory Bowel Disease Therapeutics Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 South Africa Inflammatory Bowel Disease Therapeutics Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 South Africa Inflammatory Bowel Disease Therapeutics Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 South Africa Inflammatory Bowel Disease Therapeutics Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.3.3 South Africa Inflammatory Bowel Disease Therapeutics Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.3.4 South Africa Inflammatory Bowel Disease Therapeutics Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 South Africa Inflammatory Bowel Disease Therapeutics Market Import-Export Trade Statistics |
7.1 South Africa Inflammatory Bowel Disease Therapeutics Market Export to Major Countries |
7.2 South Africa Inflammatory Bowel Disease Therapeutics Market Imports from Major Countries |
8 South Africa Inflammatory Bowel Disease Therapeutics Market Key Performance Indicators |
8.1 Patient adherence rates to prescribed IBD therapies |
8.2 Number of healthcare professionals specializing in IBD treatment |
8.3 Rate of adoption of new IBD treatment guidelines |
8.4 Patient satisfaction and quality of life improvements with IBD therapeutics |
8.5 Frequency of IBD-related hospitalizations and disease complications |
9 South Africa Inflammatory Bowel Disease Therapeutics Market - Opportunity Assessment |
9.1 South Africa Inflammatory Bowel Disease Therapeutics Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 South Africa Inflammatory Bowel Disease Therapeutics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 South Africa Inflammatory Bowel Disease Therapeutics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 South Africa Inflammatory Bowel Disease Therapeutics Market - Competitive Landscape |
10.1 South Africa Inflammatory Bowel Disease Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 South Africa Inflammatory Bowel Disease Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |